5AM Venture Management, LLC Long-Term Concentrated

CIK: 0001799883 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 3, 2022

Total Value ($000): $532,794 (100.0% shares, 0.0% debt)

Holdings (17)

PEAR THERAPEUTICS INC 21.7%
Value ($000) $115,517 Shares 18,631,771 Est. Cost $6.20 Unrealized
TRDA ENTRADA THERAPEUTICS INC 14.2%
Value ($000) $75,471 Shares 4,408,379 Est. Cost $17.12 Unrealized
VOR BIOPHARMA INC 13.9%
Value ($000) $73,923 Shares 6,361,723 Est. Cost $43.10 Unrealized
RALLYBIO CORP 7.5%
Value ($000) $39,980 Shares 4,190,724 Est. Cost $17.58 Unrealized
AKOUOS INC 6.6%
Value ($000) $35,154 Shares 4,135,784 Est. Cost $22.50 Unrealized
IDYA IDEAYA BIOSCIENCES INC 6.2%
Value ($000) $33,050 Shares 1,398,066 Est. Cost $7.13 Unrealized +225.6%
ARVN ARVINAS INC 6.2%
Value ($000) $32,856 Shares 400,000 Est. Cost $29.28 Unrealized +178.0%
IMPEL NEUROPHARMA INC 4.7%
Value ($000) $24,896 Shares 2,884,791 Est. Cost $8.85 Unrealized
CRNX CRINETICS PHARMACEUTICALS IN 4.6%
Value ($000) $24,498 Shares 862,286 Est. Cost $19.04 Unrealized +29.5%
SCPHARMACEUTICALS INC 3.6%
Value ($000) $19,234 Shares 3,831,474 Est. Cost $5.92 Unrealized
HOMOLOGY MEDICINES INC 3.1%
Value ($000) $16,511 Shares 4,535,919 Est. Cost $20.70 Unrealized
IVERIC BIO INC 2.0%
Value ($000) $10,755 Shares 643,248 Est. Cost $16.24 Unrealized
RNAM AVIDITY BIOSCIENCES INC 1.7%
Value ($000) $9,283 Shares 390,555 Est. Cost $21.74 Unrealized +9.9%
JANX JANUX THERAPEUTICS INC 1.7%
Value ($000) $8,805 Shares 446,266 Est. Cost $22.27 Unrealized -5.9%
CABA CABALETTA BIO INC 1.5%
Value ($000) $7,824 Shares 2,064,263 Est. Cost $11.85 Unrealized -10.0%
5 01 ACQUISITION CORP 0.7%
Value ($000) $3,596 Shares 365,126 Est. Cost $10.17 Unrealized
CIDARA THERAPEUTICS INC 0.3%
Value ($000) $1,441 Shares 1,134,511 Est. Cost $3.84 Unrealized